ID   SPHi001-A
AC   CVCL_A4UA
SY   SLEi002HZY
DR   BioSamples; SAMEA7976390
DR   hPSCreg; SPHi001-A
DR   Wikidata; Q107116955
RX   PubMed=33516123;
CC   From: Shenzhen People's Hospital; Shenzhen; China.
CC   Population: Chinese; Han.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3201; Systemic lupus erythematosus
DI   ORDO; Orphanet_536; Systemic lupus erythematosus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   30Y
CA   Induced pluripotent stem cell
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=33516123; DOI=10.1016/j.scr.2021.102192;
RA   Li D.-D., Hong X.-P., Li W.-L., Meng S.-H., Yu H.-Y., Zhang X.-H.,
RA   Wang C.-H., Samokhvalov I.M., Liu D.-Z., Tang D.-G., Dai Y.;
RT   "Establishment of an induced pluripotent stem cell line SPHi001-A from
RT   a systemic lupus erythematosus patient combined with preeclampsia and
RT   psoriasis.";
RL   Stem Cell Res. 51:102192-102192(2021).
//